NON-ENGRAFTMENT AFTER ABMT CAN BE REVERSIBLE ON CD8 INVIVO THERAPY

被引：0
|
作者：
FAVROT, MC
PHILIP, T
MORISSET, J
COMBARET, V
BERNARD, A
机构：
[1] CTR LEON BERARD,F-69373 LYON 2,FRANCE
[2] INST GUSTAVE ROUSSY,F-94805 VILLEJUIF,FRANCE
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1987年 / 15卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：317 / 317
页数：1
相关论文
共 50 条
  • [41] CD4 cells can be more efficient at tumor rejection than CD8 cells
    Perez-Diez, Ainhoa
    Joncker, Nathalie T.
    Choi, Kyungho
    Chan, William F. N.
    Anderson, Colin C.
    Lantz, Olivier
    Matzinger, Polly
    BLOOD, 2007, 109 (12) : 5346 - 5354
  • [42] THE ROLE OF PURIFIED CD8(+) T-CELLS IN GRAFT-VERSUS-LEUKEMIA ACTIVITY AND ENGRAFTMENT AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    PALATHUMPAT, V
    DEJBAKHSHJONES, S
    STROBER, S
    TRANSPLANTATION, 1995, 60 (04) : 355 - 361
  • [43] CD8 T cell immunity after respiratory viral infection is transient, while CD8 T cell immunity after epidermal vaccination is lung focused and durable
    Tian, T.
    Pan, Y.
    Pan, T.
    Williams, J. B.
    Rotrosen, E.
    Yan, Y.
    Kupper, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S10 - S10
  • [44] LINEAGE RELATIONSHIPS AND DEVELOPMENTAL KINETICS OF IMMATURE THYMOCYTES - CD3, CD4, AND CD8 ACQUISITION INVIVO AND INVITRO
    PETRIE, HT
    HUGO, P
    SCOLLAY, R
    SHORTMAN, K
    JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06): : 1583 - 1588
  • [45] Signals through CD8 or CD4 can induce commitment to the CD4 lineage in the thymus
    Bommhardt, U
    Cole, MS
    Tso, JY
    Zamoyska, R
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (05) : 1152 - 1163
  • [46] Distinct thresholds for CD8 T cell activation lead to functional heterogeneity: CD8 T cell priming can occur. independently of cell division
    Auphan-Anezin, N
    Verdeil, G
    Schmitt-Verhulst, AM
    JOURNAL OF IMMUNOLOGY, 2003, 170 (05): : 2442 - 2448
  • [47] SOLUBLE CD8 AND CD25 IN SERUM OF PATIENTS AFTER HEART-TRANSPLANTATION
    WIJNGAARD, PLJ
    VANDERMEULEN, A
    MEYLING, FHJG
    DEJONGE, N
    SCHUURMAN, HJ
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 97 (03): : 505 - 509
  • [48] Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
    Shinodaa, Koji
    Lia, Rui
    Rezk, Ayman
    Mexhitaj, Ina
    Patterson, Kristina R.
    Kakara, Mihir
    Zuroff, Leah
    Bennett, Jeffrey L.
    von Buedingen, H. -Christian
    Carruthers, Robert
    Edwards, Keith R.
    Fallis, Robert
    Giacomini, Paul S.
    Greenberg, Benjamin M.
    Hafler, David A.
    Ionete, Carolina
    Kaunzner, Ulrike W.
    Lock, Christopher B.
    Longbrake, Erin E.
    Pardo, Gabriel
    Piehl, Fredrik
    Weber, Martin S.
    Ziemssen, Tjalf
    Jacobs, Dina
    Gelfand, Jeffrey M.
    Cross, Anne H.
    Cameron, Briana
    Musch, Bruno
    Winge, Ryan C.
    Jia, Xiaoming
    Harp, Christopher T.
    Herman, Ann
    Bar-Ora, Amit
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (03)
  • [49] CD38 modulates CD8 TRM responses after respiratory viral infection
    Santos, Gislane de Almeida
    Wu, Yue
    Sen Chaudhuri, Arka
    Tang, Jinyi
    Cheon, In Su
    Narasimhan, Harish
    Sun, Jie
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [50] Novel synthetic vesicle for rapid in vivo expansion of CD8 T cells can significantly improve checkpoint inhibitor therapy
    Lilo, Adrienne V.
    Eby, Jackson K.
    DeMuth, Peter C.
    Irvine, Darrell J.
    CANCER RESEARCH, 2015, 75
12345